Jérôme Jeanblanc
9PUBLICATIONS
30CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Mar 17, 2026
Correction: Histamine H3 Receptor as a target for alcohol use disorder: challenging the predictability of animal models for clinical translation in drug development.Bernard Le Foll, Mickael Naassila, Jérôme Jeanblanc
|Jan 29, 2026
Histamine H3 Receptor as a target for alcohol use disorder: challenging the predictability of animal models for clinical translation in drug development.Bernard Le Foll, Mickael Naassila, Jérôme Jeanblanc
|Mar 30, 2024
Epigenetic drugs and psychedelics as emerging therapies for alcohol use disorder: insights from preclinical studies.Fahd François Hilal, Jerome Jeanblanc, Chloé Deschamps
|Oct 27, 2022
Plasma tau, NfL, GFAP and UCHL1 as candidate biomarkers of alcohol withdrawal-associated brain damage: A pilot study.Virgile Clergue-Duval, Agathe Vrillon, Jérôme Jeanblanc
|Nov 17, 2021
Psilocybin targets a common molecular mechanism for cognitive impairment and increased craving in alcoholism.Marcus W Meinhardt, Simone Pfarr, Grégory Fouquet
Pageof 2
Frequent Collaborators
9 joint publications
Mickaël Naassila
2 joint publications
Florence Vorspan
2 joint publications
Olivier Pierrefiche
2 joint publications
Jesus Chavarria
2 joint publications
Pablo M Rusjan
2 joint publications
Isabelle Boileau
2 joint publications
Bernard Le Foll
2 joint publications
Virgile Clergue-Duval
1 joint publications
Victor Echeverry-Alzate
1 joint publications
Laurence Labat
